Whilst these studies suggest that Nrf2 activation presents new opportunities for treatment of NASH patients with hepatic fibrosis, it is important to bear in mind that NASH is closely related to overnutrition, insulin resistance, and obesity and not to a deficiency of amino acids such as methionine and choline [86]. This evidence concerns the gene NFE2L2 and Hepatic fibrosis.